Osil Plus Capsule is a health supplement designed to promote optimal vascular function and support overall body wellness. It combines Troxerutin and Calcium Dobesilate, two powerful ingredients known to enhance capillary strength and improve circulation. This formulation helps manage venous insufficiency, supports healthy blood flow, and ensures proper nutrient delivery to tissues and organs. By maintaining vascular integrity and improving microcirculation, Osil Plus Capsule contributes to better oxygen and nutrient supply, which supports energy levels and overall vitality. It is ideal for individuals looking to maintain healthy blood vessels, support tissue health, and address nutritional deficiencies.
Key Benefits and Uses
-
Troxerutin: Strengthens capillaries, reduces abnormal leakage, and supports venous health in conditions like hemorrhoids and lower limb venous insufficiency
-
Calcium Dobesilate: Essential mineral that promotes healthy venous circulation and reduces blood viscosity
-
Decreases platelet aggregation, improving smooth blood flow
-
Enhances tissue oxygenation by improving blood supply to organs
-
Supports vascular health and reduces the risk of circulatory discomfort
-
Contributes to overall wellness by maintaining microvascular and tissue integrity
Dosage and Directions
-
Take as recommended by your healthcare provider to ensure optimal results
Indications
-
Supports nutritional balance and addresses deficiencies affecting vascular health
Storage Instructions
-
Store in a cool, dry, and dark place
-
Protect from direct sunlight to maintain potency and effectiveness
Safety Information
-
Follow the recommended dosage strictly
-
Keep out of reach and sight of children
-
Read the product label carefully before use
Product Variants & Keywords:
Osil Plus Capsule, Osil Plus, Osil Troxerutin Capsule, Osil Calcium Dobesilate, Osil Vascular Health Capsule, Osil Circulation Support, Buy Osil Plus Capsule, Osil Supplement, Osil Blood Circulation Capsule, Osil Nutritional Supplement.
Reviews
There are no reviews yet.